Grappone Conference Center
70 Constitution Avenue
Concord, NH 03301
ICER will develop a report reviewing the clinical effectiveness and value of abuse-deterrent opioids. The report will be the subject of a July 20, 2017 meeting of the New England CEPAC.
ICER’s Draft Scoping Document for a review of abuse-deterrent opioid formulations. This scoping document was open to public comment for three weeks.
Public Comment on Draft Scoping Document.